← Article
The hook

A subsidiary that bought its global parent

In 2020, listed Indian manufacturer GMM Pfaudler acquired a 54% stake in its global parent, Pfaudler Group. By 2022 it owned 100%, becoming the ultimate parent of a glass-lined equipment leader with over 40% global share.

1/10
Context

What GMM Pfaudler actually makes

It supplies engineered equipment and process systems for chemicals, pharmaceuticals, semiconductors and energy. Its core is corrosion-resistant glass-lined steel, plus seals, mixers, filtration and fluoropolymer linings. It holds about 50% domestic share and over 40% globally.

2/10
Context

A decisive shift in structure and markets

Management is moving from a regionally decentralized model to four global product divisions: corrosion-resistant technologies, process performance, heavy engineering, and process systems. It is also diversifying beyond pharma and chemical capex into nuclear, defense, semiconductors and minerals.

3/10
The story

The reverse acquisition that flipped the group

GMM Pfaudler was the Indian subsidiary, founded in 1962 as Gujarat Machinery Manufacturers. In August 2020 it agreed to buy 54% of Pfaudler Group from DBAG for about $27.4 million. The remaining 46% was acquired in September 2022.

4/10
The story

A century of proprietary material science

The company traces its DNA to 1884, when Caspar Pfaudler fused glass to steel for brewing. That became Glasteel, used in the first glass-lined chemical equipment in 1923. Proprietary technologies now include ARG, anti-static glass, and Cryo-Lock modular agitators.

5/10
The story

Diversification is reordering order intake

Non-traditional industries—oil and gas, metals and minerals, defense, nuclear, semiconductors—reached 43% of FY26 order intake, up from 31% in FY24. A €33.2 million European defense acid-recovery order and a ₹130 crore nuclear order underline the shift.

Non-traditional share of order intake (% of order intake)
31FY2443FY26
As reported
6/10
By the numbers

Record orders, but muted profit growth

₹3,714 CrFY26 order intake

FY26 consolidated revenue rose 10.1% to ₹3,523.94 crore. Order intake jumped 19.8% to ₹3,714 crore, and backlog reached ₹2,194 crore. Adjusted EBITDA was ₹403 crore at an 11.4% margin; consolidated PAT was ₹51.82 crore.

Consolidated revenue (₹ crore)
3,199FY253,524FY26
As reported
7/10
What it means

Backlog is building, cash is converting

The unexecuted order backlog rose 34.1% to ₹2,194 crore in FY26. About 70% of current orders have 10–12 month execution cycles. Free cash flow reached ₹367 crore, a free cash flow-to-EBITDA conversion above 90%.

Order backlog (₹ crore)
1,636FY252,194FY262,289Q1 FY27
As reported
8/10
What it means

The honest counter-case is margin and debt

1.9xNet debt / EBITDA

Consolidated PAT remains thin and restructuring costs are real: Hyderabad and UK site closures, and German workforce cuts. Gross debt is ₹1,437 crore, including pension and lease liabilities. Net debt to EBITDA is 1.9x, and Europe's chemical weakness persists.

9/10
Read on

A global moat, still proving its pivot

The full article lays out the technology, financials and risks in detail. If this deck left you informed, read the deep dive to understand the competitive landscape, tax restructuring and what could go right or wrong next.

Read the full analysis →
10/10
Swipe →